Skip to content

Dietary Maneuvers to Reduce Production of Colon-Derived Uremic Solutes

Dietary Maneuvers to Reduce Production of Colon-Derived Uremic Solutes

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01186276
Enrollment
58
Registered
2010-08-23
Start date
2010-07-31
Completion date
2015-09-30
Last updated
2022-08-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Kidney Failure, Chronic

Brief summary

This study will assess whether dietary fiber supplements can reduce the production of chemicals which are produced by colon bacteria and normally excreted from the body by the kidney, but build up in the body in patients on hemodialysis.

Detailed description

The study procedures will consist of: * taking a dietary supplement containing either fiber or starch (starch serves as a control for fiber) for six weeks. The fiber dose initially employed will be 30 g/day of high amylose corn and the control starch dose employed will be 30 g/day of waxy corn starch. Supplements which come in dry powder form will be mixed in liquid or food for consumption. * filling out a food record and a quality of life questionnaire * keeping a diary of any gi symptoms * collecting samples of blood, spent dialysate, urine(if the patient still makes urine) and stool.

Interventions

DIETARY_SUPPLEMENTFiber

Dietary fiber supplements to be consumed daily for 6 weeks.

DIETARY_SUPPLEMENTCorn starch

Corn starch to be consumed daily for 6 weeks. This will serve as the control/placebo arm.

Sponsors

National Institutes of Health (NIH)
CollaboratorNIH
Stanford University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* stable dialysis patients able to provide consent.

Exclusion criteria

-- known g.i. disease * use of antibiotics for the last two month or expected antibiotic use * recent hospitalization or other event resulting in instability of food intake

Design outcomes

Primary

MeasureTime frame
Plasma level of p-cresol sulfate8 weeks

Secondary

MeasureTime frame
Caloric intake8 weeks

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026